US
Us Congress Senate Bill SB2529

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB2529

Introduced
7/30/25  

Caption

A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches.

Latest US SB2529 Activity

View All Events: US 2025-2026 Regular Session SB2529

Companion Bills

No companion bills found.

Previously Filed As

US SB5617

A bill to provide for debt reduction for developing countries for purposes of climate adaptation, and for other purposes.

US HB10208

DIPLOMA Act Developing Innovative Partnerships and Learning Opportunities that Motivate Achievement Act

US HB9979

Scientific EXPERT Act of 2024 Scientific External Process for Educated Review of Therapeutics Act of 2024

US SB5633

A bill to establish Medicare flex fund accounts and for other purposes.

US SB2529

A bill to provide support for military families with dependents in the Exceptional Family Member Program.

US SB5298

Health Marketplace for All Act of 2024

US HB4499

IDEA Act of 2023 Increasing and Developing Entrepreneurship Access Act of 2023

US HB7521

Protecting Americans from Foreign Adversary Controlled Applications Act

US HB8725

Increasing Medication Access for Seniors Act of 2024

US HB4766

Clarity for Payment Stablecoins Act of 2023

Similar Bills

CA AB1060

Health care coverage: naloxone hydrochloride.

ME LD163

An Act to Require Health Insurance Coverage for Federally Approved Nonprescription Oral Hormonal Contraceptives and Nonprescription Emergency Contraceptives

ME LD2203

An Act to Require Health Insurance Coverage for Federally Approved Nonprescription Oral Hormonal Contraceptives and Nonprescription Emergency Contraceptives

CA AB602

Pharmacy: nonprescription diabetes test devices.

CA AB309

Hypodermic needles and syringes.

CA AB2077

Hypodermic needles and syringes.

CA AB2271

St. Rose Hospital.

LA HB82

Limits the sale and purchase of products containing dextromethorphan (OR INCREASE GF EX See Note)